Skip to main content
Clinical Trials/NCT05598931
NCT05598931
Completed
Not Applicable

Development of Neuro-Navigated Transcranial Magnetic Stimulation (TMS) Using MRI

Soterix Medical1 site in 1 country20 target enrollmentJuly 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Treatment Resistant Depression
Sponsor
Soterix Medical
Enrollment
20
Locations
1
Primary Endpoint
Brain Coordinates
Status
Completed
Last Updated
7 months ago

Overview

Brief Summary

Healthy controls (HC) will be studied once to provide data needed to validate the virtual neuro-navigation system. All subjects will undergo a single MRI session and will then participate in an on-line neuro-navigation session in which various TMS coil positions will be recorded. The brain/head images will be provided to the programmer to permit development of the virtual neuro-navigation algorithm. Data from Yr1 will be used by the programmer as a training sample, and from Yr2 as a test sample.

Detailed Description

HC subjects (n=10)/yr will be studied once to provide data needed to validate the virtual neuro-navigation system. All subjects will undergo a single Human Connectome Project compatible MRI session permitting application of both surface-based and more standard volumetric analyses. Subjects will then participate in an on-line neuro-navigation session in which TMS coil positions (in 10/20 coordinate space) will be recorded corresponding to the following targets: 1) hand-representation of motor strip; 2) 5-cm location; 3) 5.5 cm location; 4) MNI coordinates corresponding to the "Fitzgerald"4 and "Weigand"6 volumetric targets; 5) peak anti-correlated region (calculated from rsfcfMRI data alone); 6) center of our targeted parcel, calculated using surface-based approaches. The brain/head images will be provided to the programmer to permit development of the virtual neuro-navigation algorithm. Data from Yr1 will be used by the programmer as a training sample, and from Yr2 as a test sample. The Go/No-go criterion is an interclass correlation coefficient (ICC) of \>.9 between scalp coordinates determined by on-line neuro-navigation and those determined virtually

Registry
clinicaltrials.gov
Start Date
July 1, 2021
End Date
October 1, 2024
Last Updated
7 months ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Soterix Medical
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Non-depressed subjects

Exclusion Criteria

  • Ever met criteria for a psychotic disorder (Sz, SzAff, Bipolar disorder); anorexia nervosa or bulimia nervosa within the last year
  • Unstable medical condition by history, physical exam or laboratory results
  • Contraindications to MRI (based on metal screening form)
  • Meets criteria for claustrophobia
  • Recent drug or alcohol use disorder with DSM-5 specifier of moderate or severe within 6 months, or mild within 2 months; lifetime history of IV drug use
  • A neurological or neuromuscular disorder;
  • Require medications for a general medical condition that contraindicate the TMS treatment
  • History of ketamine treatment within 6 mo
  • History of monoamine oxidase inhibitor (MAOI) within the past month
  • Lacks capacity to consent

Outcomes

Primary Outcomes

Brain Coordinates

Time Frame: Day 1

MRI based brain coordinates will be determined using newly developed neuronavigation software

Study Sites (1)

Loading locations...

Similar Trials